Business Overview
Active
Operating Status
Jun 2009
Founded
Hardware, Software
Offering Type
Description
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders at the right place and the right time. MeMeds interdisciplinary team has decades of experience and a proven track record in diverse fields including molecular immunology, informatics, clinical infectious diseases and in vitro diagnostics.
Business Stage
Launched
Sectors
Founders
Register for Pro to view
Board Members and Advisors
Investors
Investor
Investor Type
Series Preference
Convertible Note, Pre-Seed, Product Crowdfunding, Seed, Series A, Series B, Series C, Series D, Strategic
Funding Rounds
$129,700,000
Total Funding
3
Funding Rounds
Grant
Last Funding Series
Register for Pro to view
Date Announced
Funding Round
Amount Raised
Investors
AI Technology Stack™
Certifications and Approvals
Patents
Register for Pro to view
In The News
More Startups
Startup Snapshot
Operating Status
Active
Total Funding
$129,700,000
Founded
June 2009
Funding Stage
Grant
Time Since Last Funding Round
2 years
